Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-25-023217
Filing Date
2025-06-20
Accepted
2025-06-20 17:24:51
Documents
14
Period of Report
2025-07-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20050076x1_def14a.htm   iXBRL DEF 14A 726424
3 GRAPHIC ny20050076x1_pc1.jpg GRAPHIC 723928
4 GRAPHIC ny20050076x1_pc2.jpg GRAPHIC 418920
  Complete submission text file 0001140361-25-023217.txt   3980404

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA exoz-20250725.xsd EX-101.SCH 2121
16 EXTRACTED XBRL INSTANCE DOCUMENT ny20050076x1_def14a_htm.xml XML 3587
Mailing Address 750 ROYAL OAKS DR MONROVIA CA 91016
Business Address 750 ROYAL OAKS DR MONROVIA CA 91016 (626) - 415 - 1488
EXOZYMES INC. (Filer) CIK: 0002010788 (see all company filings)

EIN.: 834550057 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-42204 | Film No.: 251062400
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)